Concepts (255)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Sodium Channels | 48 | 2015 | 130 | 6.500 |
Why?
|
| Ion Channel Gating | 32 | 2010 | 329 | 3.840 |
Why?
|
| Calcium Channels, T-Type | 9 | 2010 | 25 | 2.110 |
Why?
|
| Lidocaine | 11 | 2015 | 65 | 2.110 |
Why?
|
| Muscle Proteins | 10 | 2015 | 133 | 2.040 |
Why?
|
| Membrane Potentials | 19 | 2013 | 436 | 1.630 |
Why?
|
| Calcium Channel Blockers | 6 | 2010 | 121 | 1.460 |
Why?
|
| NAV1.5 Voltage-Gated Sodium Channel | 10 | 2015 | 32 | 1.370 |
Why?
|
| Sodium Channel Blockers | 9 | 2010 | 27 | 1.360 |
Why?
|
| Protein Structure, Tertiary | 16 | 2015 | 740 | 1.110 |
Why?
|
| Anti-Arrhythmia Agents | 4 | 2010 | 65 | 1.100 |
Why?
|
| Myocardium | 14 | 2000 | 572 | 0.970 |
Why?
|
| Asparagine | 3 | 2015 | 30 | 0.850 |
Why?
|
| Spider Venoms | 3 | 2010 | 10 | 0.740 |
Why?
|
| Purkinje Fibers | 13 | 1995 | 27 | 0.720 |
Why?
|
| Mibefradil | 3 | 2006 | 3 | 0.700 |
Why?
|
| Peptides | 13 | 2009 | 649 | 0.700 |
Why?
|
| Kinetics | 24 | 2007 | 1534 | 0.640 |
Why?
|
| Verapamil | 2 | 2010 | 34 | 0.640 |
Why?
|
| Anesthetics, Local | 4 | 2010 | 77 | 0.630 |
Why?
|
| Models, Molecular | 13 | 2011 | 1315 | 0.590 |
Why?
|
| Mutagenesis, Site-Directed | 15 | 2010 | 283 | 0.580 |
Why?
|
| Sodium | 12 | 2010 | 331 | 0.580 |
Why?
|
| Cell Line | 18 | 2010 | 2495 | 0.570 |
Why?
|
| Arginine | 7 | 2013 | 138 | 0.540 |
Why?
|
| Patch-Clamp Techniques | 13 | 2013 | 396 | 0.530 |
Why?
|
| Calcium Channels | 2 | 2011 | 182 | 0.490 |
Why?
|
| Heart | 9 | 2004 | 574 | 0.460 |
Why?
|
| Electric Conductivity | 12 | 2010 | 144 | 0.410 |
Why?
|
| Calcium | 10 | 2000 | 1179 | 0.400 |
Why?
|
| Electrophysiology | 16 | 2006 | 403 | 0.400 |
Why?
|
| Animals | 53 | 2015 | 27511 | 0.390 |
Why?
|
| Transfection | 10 | 2009 | 909 | 0.370 |
Why?
|
| Dogs | 21 | 2000 | 705 | 0.370 |
Why?
|
| Amino Acid Substitution | 7 | 2015 | 338 | 0.370 |
Why?
|
| Benzocaine | 2 | 2009 | 2 | 0.370 |
Why?
|
| Dose-Response Relationship, Drug | 10 | 2010 | 1929 | 0.370 |
Why?
|
| Cardiac Electrophysiology | 1 | 2010 | 7 | 0.360 |
Why?
|
| Connexins | 3 | 2009 | 202 | 0.360 |
Why?
|
| Amino Acid Sequence | 13 | 2015 | 2063 | 0.340 |
Why?
|
| Binding Sites | 11 | 2009 | 1121 | 0.330 |
Why?
|
| Cardiology | 1 | 2010 | 115 | 0.330 |
Why?
|
| Cnidarian Venoms | 5 | 2006 | 19 | 0.320 |
Why?
|
| Molecular Sequence Data | 13 | 2015 | 3024 | 0.320 |
Why?
|
| Recombinant Proteins | 9 | 2004 | 1008 | 0.320 |
Why?
|
| Rats | 16 | 2015 | 4048 | 0.320 |
Why?
|
| Protein Conformation | 7 | 2010 | 895 | 0.310 |
Why?
|
| Ethyl Methanesulfonate | 2 | 2005 | 4 | 0.310 |
Why?
|
| Cardiotonic Agents | 4 | 1996 | 89 | 0.300 |
Why?
|
| Structure-Activity Relationship | 6 | 2011 | 414 | 0.300 |
Why?
|
| Purkinje Cells | 4 | 1993 | 84 | 0.300 |
Why?
|
| Atrial Natriuretic Factor | 3 | 1991 | 39 | 0.290 |
Why?
|
| Cell Membrane | 3 | 2008 | 677 | 0.280 |
Why?
|
| Venoms | 1 | 2006 | 12 | 0.280 |
Why?
|
| Myocardial Contraction | 4 | 1998 | 252 | 0.280 |
Why?
|
| Humans | 37 | 2015 | 89768 | 0.270 |
Why?
|
| Mesylates | 4 | 2010 | 15 | 0.260 |
Why?
|
| Oocytes | 2 | 2009 | 219 | 0.240 |
Why?
|
| Polyamines | 1 | 2004 | 37 | 0.230 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 11 | 2004 | 182 | 0.230 |
Why?
|
| Muscle, Skeletal | 5 | 2006 | 471 | 0.230 |
Why?
|
| Cardiovascular Diseases | 1 | 2010 | 715 | 0.220 |
Why?
|
| Endocytosis | 2 | 1994 | 180 | 0.210 |
Why?
|
| Molecular Structure | 4 | 2010 | 293 | 0.210 |
Why?
|
| Cations, Divalent | 2 | 1992 | 39 | 0.210 |
Why?
|
| Lanthanum | 2 | 1992 | 16 | 0.210 |
Why?
|
| Kidney | 2 | 2004 | 1148 | 0.190 |
Why?
|
| HEK293 Cells | 2 | 2015 | 646 | 0.190 |
Why?
|
| In Vitro Techniques | 10 | 2002 | 996 | 0.190 |
Why?
|
| Models, Biological | 5 | 2008 | 1765 | 0.180 |
Why?
|
| Insecticides | 1 | 2000 | 27 | 0.180 |
Why?
|
| Point Mutation | 1 | 2000 | 245 | 0.170 |
Why?
|
| Toxins, Biological | 1 | 1999 | 7 | 0.160 |
Why?
|
| Protein Structure, Secondary | 5 | 2011 | 333 | 0.160 |
Why?
|
| Saxitoxin | 5 | 2000 | 8 | 0.150 |
Why?
|
| Peripheral Nervous System Neoplasms | 1 | 1996 | 19 | 0.130 |
Why?
|
| Drosophila melanogaster | 1 | 2000 | 614 | 0.130 |
Why?
|
| Porosity | 1 | 2015 | 61 | 0.130 |
Why?
|
| Cyclic AMP | 2 | 1995 | 277 | 0.130 |
Why?
|
| Colforsin | 1 | 1995 | 74 | 0.120 |
Why?
|
| Extracellular Space | 3 | 2010 | 92 | 0.120 |
Why?
|
| Isoquinolines | 1 | 1994 | 73 | 0.120 |
Why?
|
| Chymotrypsin | 1 | 1993 | 28 | 0.110 |
Why?
|
| Mutation | 5 | 2008 | 4164 | 0.110 |
Why?
|
| Potassium Channels | 2 | 2011 | 346 | 0.110 |
Why?
|
| Electrochemistry | 3 | 2000 | 60 | 0.110 |
Why?
|
| Scorpion Venoms | 2 | 2006 | 25 | 0.110 |
Why?
|
| Sea Anemones | 5 | 2006 | 16 | 0.110 |
Why?
|
| Biophysics | 3 | 2006 | 153 | 0.110 |
Why?
|
| Heart Conduction System | 6 | 1988 | 112 | 0.100 |
Why?
|
| Phenylalanine | 2 | 2009 | 36 | 0.100 |
Why?
|
| Cells, Cultured | 5 | 2004 | 2887 | 0.100 |
Why?
|
| Barium | 3 | 2000 | 31 | 0.100 |
Why?
|
| Casein Kinase Idelta | 1 | 2011 | 2 | 0.100 |
Why?
|
| Hydrogen-Ion Concentration | 3 | 2006 | 503 | 0.090 |
Why?
|
| Protein Isoforms | 3 | 2011 | 276 | 0.090 |
Why?
|
| Gap Junctions | 2 | 2009 | 144 | 0.090 |
Why?
|
| Receptors, AMPA | 1 | 2011 | 66 | 0.090 |
Why?
|
| Mechanoreceptors | 1 | 1991 | 36 | 0.090 |
Why?
|
| Biotin | 2 | 2009 | 45 | 0.090 |
Why?
|
| Biophysical Phenomena | 2 | 2002 | 124 | 0.090 |
Why?
|
| Heart Atria | 4 | 1994 | 282 | 0.090 |
Why?
|
| Nucleus Accumbens | 1 | 2011 | 113 | 0.090 |
Why?
|
| Amphetamine | 1 | 2011 | 103 | 0.090 |
Why?
|
| Ion Channels | 6 | 2008 | 246 | 0.090 |
Why?
|
| History, 21st Century | 1 | 2010 | 184 | 0.080 |
Why?
|
| Cysteine | 2 | 2007 | 137 | 0.080 |
Why?
|
| Static Electricity | 3 | 2007 | 90 | 0.080 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2010 | 200 | 0.080 |
Why?
|
| History, 20th Century | 1 | 2010 | 314 | 0.080 |
Why?
|
| Motor Activity | 1 | 2011 | 327 | 0.080 |
Why?
|
| Tumor Cells, Cultured | 4 | 1999 | 1048 | 0.080 |
Why?
|
| Spiders | 1 | 2008 | 16 | 0.080 |
Why?
|
| Electric Stimulation | 2 | 2000 | 365 | 0.080 |
Why?
|
| Alternative Splicing | 2 | 2006 | 212 | 0.070 |
Why?
|
| Gene Expression | 2 | 2005 | 1309 | 0.070 |
Why?
|
| Brain | 2 | 2006 | 2303 | 0.070 |
Why?
|
| Magnesium | 3 | 1992 | 178 | 0.070 |
Why?
|
| Voltage-Gated Sodium Channel beta-3 Subunit | 1 | 2006 | 1 | 0.070 |
Why?
|
| NAV1.3 Voltage-Gated Sodium Channel | 1 | 2006 | 1 | 0.070 |
Why?
|
| Cell Membrane Permeability | 1 | 2007 | 120 | 0.070 |
Why?
|
| Calcium Channels, L-Type | 1 | 2006 | 38 | 0.070 |
Why?
|
| Protons | 1 | 2006 | 101 | 0.070 |
Why?
|
| Marine Toxins | 2 | 1996 | 7 | 0.070 |
Why?
|
| Sulfhydryl Reagents | 1 | 2005 | 8 | 0.060 |
Why?
|
| Lysine | 2 | 2007 | 150 | 0.060 |
Why?
|
| Papillary Muscles | 3 | 1999 | 17 | 0.060 |
Why?
|
| Epilepsy, Generalized | 1 | 2006 | 40 | 0.060 |
Why?
|
| Sarcoplasmic Reticulum | 2 | 1998 | 25 | 0.060 |
Why?
|
| Tetrodotoxin | 4 | 1993 | 50 | 0.060 |
Why?
|
| Polyelectrolytes | 1 | 2004 | 6 | 0.060 |
Why?
|
| Xenopus laevis | 1 | 2004 | 138 | 0.060 |
Why?
|
| Serine | 1 | 2004 | 105 | 0.060 |
Why?
|
| Glycine | 1 | 2003 | 95 | 0.060 |
Why?
|
| Time Factors | 6 | 1995 | 5349 | 0.050 |
Why?
|
| Nickel | 2 | 1992 | 13 | 0.050 |
Why?
|
| Cobalt | 2 | 1992 | 30 | 0.050 |
Why?
|
| Cadmium | 2 | 1992 | 28 | 0.050 |
Why?
|
| Peptide Fragments | 1 | 2004 | 462 | 0.050 |
Why?
|
| Genetic Variation | 2 | 2006 | 1380 | 0.050 |
Why?
|
| Manganese | 2 | 1992 | 55 | 0.050 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2006 | 663 | 0.050 |
Why?
|
| Zinc | 2 | 1992 | 95 | 0.050 |
Why?
|
| RNA | 1 | 2006 | 583 | 0.050 |
Why?
|
| Rats, Inbred Strains | 2 | 1991 | 312 | 0.050 |
Why?
|
| Rabbits | 2 | 1993 | 640 | 0.050 |
Why?
|
| Insecticide Resistance | 1 | 2000 | 9 | 0.050 |
Why?
|
| Protein Binding | 3 | 2004 | 1491 | 0.050 |
Why?
|
| Isoproterenol | 2 | 1993 | 62 | 0.050 |
Why?
|
| Temperature | 2 | 2000 | 409 | 0.040 |
Why?
|
| Indicators and Reagents | 1 | 2000 | 72 | 0.040 |
Why?
|
| Computer Simulation | 1 | 2004 | 1101 | 0.040 |
Why?
|
| Cell Line, Transformed | 1 | 2000 | 154 | 0.040 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2011 | 1237 | 0.040 |
Why?
|
| Recombinant Fusion Proteins | 2 | 1999 | 563 | 0.040 |
Why?
|
| Cloning, Molecular | 1 | 2000 | 645 | 0.040 |
Why?
|
| Quaternary Ammonium Compounds | 1 | 1999 | 81 | 0.040 |
Why?
|
| Long QT Syndrome | 1 | 1999 | 36 | 0.040 |
Why?
|
| Glutamic Acid | 2 | 2011 | 154 | 0.040 |
Why?
|
| Sarcolemma | 1 | 1998 | 31 | 0.040 |
Why?
|
| Ryanodine Receptor Calcium Release Channel | 1 | 1998 | 25 | 0.040 |
Why?
|
| Cats | 3 | 1988 | 305 | 0.040 |
Why?
|
| Isomerism | 1 | 1997 | 29 | 0.040 |
Why?
|
| Chimera | 1 | 1997 | 56 | 0.040 |
Why?
|
| Neuroblastoma | 2 | 1999 | 400 | 0.040 |
Why?
|
| United States | 1 | 2010 | 7080 | 0.040 |
Why?
|
| Markov Chains | 1 | 1998 | 127 | 0.040 |
Why?
|
| HeLa Cells | 2 | 2009 | 515 | 0.040 |
Why?
|
| Monte Carlo Method | 1 | 1998 | 186 | 0.040 |
Why?
|
| Transcription, Genetic | 2 | 2006 | 1158 | 0.040 |
Why?
|
| Polymerase Chain Reaction | 2 | 1996 | 919 | 0.040 |
Why?
|
| Xenopus | 2 | 2009 | 126 | 0.030 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 1999 | 885 | 0.030 |
Why?
|
| Neurotoxins | 1 | 1996 | 49 | 0.030 |
Why?
|
| Cell Fusion | 1 | 1996 | 39 | 0.030 |
Why?
|
| Methods | 1 | 1996 | 151 | 0.030 |
Why?
|
| Mammals | 1 | 1999 | 237 | 0.030 |
Why?
|
| Leucine | 1 | 1996 | 60 | 0.030 |
Why?
|
| Systole | 2 | 1987 | 115 | 0.030 |
Why?
|
| Tryptophan | 1 | 1996 | 97 | 0.030 |
Why?
|
| Alanine | 2 | 2008 | 84 | 0.030 |
Why?
|
| Blotting, Northern | 1 | 1996 | 258 | 0.030 |
Why?
|
| Coated Pits, Cell-Membrane | 1 | 1994 | 6 | 0.030 |
Why?
|
| Oxazoles | 1 | 1994 | 18 | 0.030 |
Why?
|
| Potassium Channels, Voltage-Gated | 1 | 1995 | 125 | 0.030 |
Why?
|
| Subcellular Fractions | 1 | 1994 | 94 | 0.030 |
Why?
|
| Circular Dichroism | 2 | 2009 | 117 | 0.030 |
Why?
|
| Tissue Distribution | 1 | 1994 | 293 | 0.030 |
Why?
|
| Models, Cardiovascular | 2 | 1992 | 107 | 0.030 |
Why?
|
| Caffeine | 1 | 1994 | 83 | 0.030 |
Why?
|
| Sucrose | 1 | 1993 | 65 | 0.030 |
Why?
|
| Guinea Pigs | 1 | 1993 | 172 | 0.030 |
Why?
|
| Thionucleotides | 1 | 1993 | 55 | 0.030 |
Why?
|
| Fluorescent Dyes | 1 | 1994 | 245 | 0.030 |
Why?
|
| Brain Neoplasms | 1 | 1999 | 783 | 0.030 |
Why?
|
| Brefeldin A | 1 | 1991 | 10 | 0.020 |
Why?
|
| Protein Synthesis Inhibitors | 1 | 1991 | 35 | 0.020 |
Why?
|
| Base Sequence | 3 | 2006 | 2329 | 0.020 |
Why?
|
| Osmolar Concentration | 1 | 1992 | 182 | 0.020 |
Why?
|
| Biological Availability | 1 | 1992 | 91 | 0.020 |
Why?
|
| Cyclopentanes | 1 | 1991 | 27 | 0.020 |
Why?
|
| Cell Separation | 1 | 1992 | 199 | 0.020 |
Why?
|
| DNA | 1 | 1997 | 1311 | 0.020 |
Why?
|
| Microscopy, Electron | 1 | 1991 | 511 | 0.020 |
Why?
|
| Permeability | 1 | 1991 | 138 | 0.020 |
Why?
|
| Golgi Apparatus | 1 | 1991 | 116 | 0.020 |
Why?
|
| Isometric Contraction | 2 | 1988 | 42 | 0.020 |
Why?
|
| Endoplasmic Reticulum | 1 | 1991 | 255 | 0.020 |
Why?
|
| Phenotype | 1 | 1996 | 2450 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2011 | 1130 | 0.020 |
Why?
|
| Phenothiazines | 1 | 1988 | 3 | 0.020 |
Why?
|
| Sequence Deletion | 1 | 2008 | 205 | 0.020 |
Why?
|
| Microcomputers | 1 | 1987 | 26 | 0.020 |
Why?
|
| Cell Communication | 1 | 2008 | 200 | 0.020 |
Why?
|
| Aspartic Acid | 1 | 2007 | 64 | 0.020 |
Why?
|
| Veratridine | 2 | 1996 | 2 | 0.020 |
Why?
|
| Acidosis | 1 | 2006 | 55 | 0.020 |
Why?
|
| Open Reading Frames | 1 | 2006 | 121 | 0.020 |
Why?
|
| DNA, Complementary | 1 | 2006 | 391 | 0.020 |
Why?
|
| Diastole | 1 | 1985 | 141 | 0.020 |
Why?
|
| DNA Primers | 2 | 1996 | 543 | 0.010 |
Why?
|
| Mice | 4 | 2003 | 11846 | 0.010 |
Why?
|
| Female | 3 | 1993 | 46491 | 0.010 |
Why?
|
| NAV1.2 Voltage-Gated Sodium Channel | 1 | 2003 | 5 | 0.010 |
Why?
|
| Evoked Potentials | 1 | 1985 | 191 | 0.010 |
Why?
|
| Exercise | 1 | 2006 | 326 | 0.010 |
Why?
|
| Heart Ventricles | 1 | 1987 | 779 | 0.010 |
Why?
|
| Nerve Tissue Proteins | 1 | 2003 | 511 | 0.010 |
Why?
|
| Action Potentials | 3 | 1989 | 600 | 0.010 |
Why?
|
| Signal Transduction | 1 | 1991 | 3402 | 0.010 |
Why?
|
| Male | 2 | 2011 | 42578 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2003 | 2583 | 0.010 |
Why?
|
| Genes, Synthetic | 1 | 1996 | 7 | 0.010 |
Why?
|
| Isoleucine | 1 | 1996 | 19 | 0.010 |
Why?
|
| Perfusion | 2 | 1987 | 253 | 0.010 |
Why?
|
| Solubility | 1 | 1996 | 184 | 0.010 |
Why?
|
| Tetraethylammonium Compounds | 1 | 1995 | 14 | 0.010 |
Why?
|
| Delayed Rectifier Potassium Channels | 1 | 1995 | 13 | 0.010 |
Why?
|
| Tetraethylammonium | 1 | 1995 | 24 | 0.010 |
Why?
|
| Shab Potassium Channels | 1 | 1995 | 29 | 0.010 |
Why?
|
| Cations | 1 | 1995 | 30 | 0.010 |
Why?
|
| Shaker Superfamily of Potassium Channels | 1 | 1995 | 49 | 0.010 |
Why?
|
| Macromolecular Substances | 1 | 1995 | 177 | 0.010 |
Why?
|
| Hydrolysis | 1 | 1995 | 141 | 0.010 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 1995 | 418 | 0.010 |
Why?
|
| Oxidation-Reduction | 1 | 1995 | 388 | 0.010 |
Why?
|
| Forecasting | 1 | 1990 | 304 | 0.000 |
Why?
|
| Quinidine | 1 | 1988 | 11 | 0.000 |
Why?
|
| Moricizine | 1 | 1988 | 2 | 0.000 |
Why?
|
| Neurons | 1 | 1996 | 1589 | 0.000 |
Why?
|
| Decapodiformes | 1 | 1987 | 38 | 0.000 |
Why?
|
| Axons | 1 | 1987 | 181 | 0.000 |
Why?
|
| Thermodynamics | 1 | 1987 | 314 | 0.000 |
Why?
|
| Homeostasis | 1 | 1988 | 418 | 0.000 |
Why?
|
| Reaction Time | 1 | 1986 | 311 | 0.000 |
Why?
|